Analyst Ratings for AcelRx Pharmaceuticals (acrx)
acrx Rating Summary
acrx Price Target Summary
- Highest: $13.00 (Mizuho Securities)
- Lowest: $6.00 (Guggenheim)
- Average: $8.75
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.75 (+36.7%)
Avg. $ Target:
$8.75 (+36.7%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/8/2013 | Jefferies | New Coverage | Buy (N/A) |
8.00 (N/A) |
5.03 | 6.40 | 27.24% | Details |
| 1/30/2013 | Mizuho Securities | New Coverage | Outperform (N/A) |
13.00 (N/A) |
5.33 | 6.40 | 20.08% | Details |
| 10/10/2012 | Canaccord Genuity | New Coverage | Buy (N/A) |
8.00 (N/A) |
3.09 | 6.40 | 107.12% | Details |
| 9/18/2012 | Guggenheim | New Coverage | Buy (N/A) |
6.00 (N/A) |
3.45 | 6.40 | 85.51% | Details |
| 11/15/2011 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
2.95 | 6.40 | 116.95% | Details |
| 3/24/2011 | Piper Jaffray | New Coverage | Overweight (N/A) |
N/A (N/A) |
3.33 | 6.40 | 92.19% | Details |
| 3/23/2011 | JMP Securities | New Coverage | Market Outperform (N/A) |
N/A (N/A) |
3.39 | 6.40 | 88.79% | Details |
